CLINICAL_TRIALS ClinicalTrials.gov record update

Granzyme B Production as a Biomarker for the Immunomodulatory Activity of Sorafenib in HCC

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02072486
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:34.056064+00:00
Published At: 2022-07-25T00:00:00+00:00
Record Updated At: 2022-07-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Adult Hepatocellular Carcinoma", "Localized Non-Resectable Adult Hepatocellular Carcinoma", "Stage III Childhood Hepatocellular Carcinoma", "Stage IIIA Hepatocellular Carcinoma", "Stage IIIB Hepatocellular Carcinoma", "Stage IIIC Hepatocellular Carcinoma", "Stage IV Childhood Hepatocellular Carcinoma", "Stage IVA Hepatocellular Carcinoma", "Stage IVB Hepatocellular Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-07-25"
protocolSection.identificationModule.nctId: "NCT02072486"
protocolSection.identificationModule.officialTitle: "Granzyme B Production as a Biomarker for the Immunomodulatory Activity of Sorafenib in HCC"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.